Globe Life Inc. · GL · FY2025 Q2 · Calendar Q3 2025

Globe Life: Higher Guidance, Stronger Agency Growth and Bermuda Plans

The supplied analysis supports a constructive but qualified view: premium growth, agency expansion and a Direct to Consumer turnaround strengthen the operating picture, while the durability of guidance gains and execution of the Bermuda reinsurance plan remain important tests.

Why did GL rise 5.4% after beating EPS estimates in FY2025 Q2?

Research this report with FN2. Free to start; review your question before sending.

Reported After market closeNYSEFinancial Services $12.69B market cap
100quality score

Earnings scorecard

Reported versus consensus
Reported EPS $3.27 Consensus $3.25
EPS surprise +0.6% Reported versus consensus
Reported revenue $1.48B Consensus $1.51B
Revenue surprise -1.6% Reported versus consensus
Check the math in the surprise calculator >

Market reaction

event-close to next-session close
Stock move +5.4% Event window
SPY move +0.0% Same window
Abnormal move +5.3% Stock minus SPY
Volume 2.5× Versus trailing sessions
Subsequent drift +6.2% Up to 20 sessions
GLSPY benchmark

Ask FN2 about GL FY2025 Q2

Choose a question to continue your research

Free to start. Your question opens in chat for you to review and send. FN2 can look up the transcript, financials and prior quarters.

Transcript intelligence

What changed

Management raised guidance, reported continued life and health premium growth, and described stronger agency and Direct to Consumer trends. The company also advanced its Bermuda reinsurance plan, with benefits expected to begin in 2027.

Guidance delta

Raised, according to the supplied transcript analysis; the key question is how much of the uplift is recurring.

Key takeaways

  • Q2 net income was $253 million; life premiums grew 3% year over year and health premiums grew 8%.
  • Exclusive agency count increased 6% sequentially, supporting the future sales pipeline.
  • Direct to Consumer reversed a multi-year decline as underwriting automation improved conversion.
  • Management continued its share-repurchase and dividend program.
  • A Bermuda reinsurance affiliate is being developed, with expected cash-flow benefits beginning in 2027.

Management priorities

  • Finalize and launch the Bermuda reinsurance affiliate and begin ceded transactions.
  • Continue share repurchases and dividend payouts.
  • Invest in digital underwriting and lead-conversion technology for Direct to Consumer.
  • Maintain capital ratios within the 300%-320% RBC target range.

Follow GL with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Earnings History

Estimate Beat Miss Match
GL REVENUE earnings history estimate and actual scatter chart 10 reported fiscal quarters and 4 future estimate-only quarters. Q4 '23 actual $1B, None Q1 '24 estimate $1B Q1 '24 actual $1B, miss Q2 '24 estimate $1B Q2 '24 actual $1B, miss Q3 '24 estimate $1B Q3 '24 actual $1B, miss Q2 '25 estimate $2B Q2 '25 actual $1B, miss Q3 '25 estimate $2B Q3 '25 actual $2B, miss Q4 '25 estimate $2B Q4 '25 actual $2B, miss Q1 '26 estimate $2B Q1 '26 actual $2B, miss Q2 '26 estimate $2B Q2 '26 actual $2B, beat Q3 '26 estimate $2B Q3 '26 actual $2B, beat Q4 '26 estimate $2B Q1 '27 estimate $2B Q2 '27 estimate $2B Q3 '27 estimate $2B
Show less

Analyst Consensus ?

ConsensusHold28 ratings
Bullish932.1%
Neutral1242.9%
Bearish725.0%

Analyst 52W Price Targets

$151.65Current
$90Low
$162.06Average
$215High

Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Nov 22, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
Wells Fargo Overweight OverweightMaintainOct 26, 2026
TD Cowen Buy BuyMaintainOct 23, 2026
Piper Sandler Neutral OverweightDowngradeOct 23, 2026
Evercore ISI Group In Line In LineMaintainOct 23, 2026
JP Morgan Overweight OverweightMaintainOct 15, 2026
Show 23 more rating actions

Named analyst price targets

Upside is calculated against the persisted current price $151.65. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
Raymond JamesWilma Burdis$208$161.8 +37.2%Nov 12, 2026
KBWAnalyst unavailable$182$156.82 +20.0%Oct 26, 2026
Wells FargoWesley Carmichael$180$154.79 +18.7%Oct 26, 2026
TD CowenAnalyst unavailable$215$154.79 +41.8%Oct 23, 2026
UBSAnalyst unavailable$165$168.41 +8.8%Oct 23, 2026
See 33 more

Track every rating change on GL the moment it posts. Free to start.

Start free

Company context

Snapshot as of publication

Globe Life Inc. delivers diverse life insurance and supplementary health coverage, alongside annuity products, targeting households in the lower-middle to middle-income brackets throughout the United States. The company's operations are structured into four key segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. Its offerings encompass whole life, term life, and other life protection plans; supplemental health benefits like Medicare supplements, critical illness, and accident policies; and both single-premium and flexible-premium deferred annuities. Founded in 1979 and headquartered in McKinney, Texas, the enterprise rebranded from Torchmark Corporation to Globe Life Inc. in August 2019.

Historical context

All GL earnings

Financial Services peers this season

Latest reports in the same sector

Latest beats and misses

Who reports next

Get the GL recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

  1. Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
  2. FN2 earnings calendar · 2026-07-26T00:37:55.686058+00:00
  3. Polygon adjusted daily market bars · 2026-10-08T10:00:43.731622+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-08T10:00:43.728535+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated · As of 2026-10-08. For educational purposes only; not investment advice.